RxDoctor Payments Data

David Sperling, MD

Vascular & Interventional Radiology · New York, NYNPI 1255339420

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Sirtex Medical Inc at 48.3% of the total. Reporting peaked in 2019 at $16,043 and has fallen 70.3% since, to $4,770 in 2025.

$42,479in general payments, 2019–2025

Across 87 payments — averaging $488.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sirtex Medical Inc$21K
  • Siemens Medical Solutions USA, Inc.$14K
  • Merit Medical Systems Inc$6K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$440
  • Trisalus Life Sciences, Inc.$354
  • Penumbra, Inc.$344
  • plus $689 from 12 others

What the payments were for

  • Consulting fees$18,85044%
  • Speaking & faculty fees$17,69042%
  • Travel & lodging$3,4228%
  • Food & beverage$2,5176%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,479 in reported general payments places this provider in the 85th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York

Medicare billing

Part B allowed, 2024
$458,264
Medicare patients
189
Services billed
3,689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →